title: A carbamazepine trial in chronic, treatment-refractory schizophrenia.
abstract: Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.
authors.affiliation: Clinical Research Unit, Metropolitan State Hospital, Norwalk, CA 90650.
authors.forename: J
authors.initials: J
authors.lastname: Sramek
authors.forename: J
authors.initials: J
authors.lastname: Herrera
authors.forename: J
authors.initials: J
authors.lastname: Costa
authors.forename: C
authors.initials: C
authors.lastname: Heh
authors.forename: T
authors.initials: T
authors.lastname: Tran-Johnson
authors.forename: G
authors.initials: G
authors.lastname: Simpson
mesh_terms: D000328:Adult; D002220:Carbamazepine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D002220:Carbamazepine